Concepedia

Stephen B. Freedman

SB

5

Publications

254

Citations

5

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Stephen B. Freedman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1988–1992

5

Publications

5

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders, Stephen B. Freedman, Elizabeth A. Harley et al. · Journal of Medicinal Chemistry · 1990 · 157 citations

, , +17

Synthesis and muscarinic activity of quinuclidinyl- and (1-azanorbornyl)pyrazine derivatives

Leslie J. Street, R. BAKER, Tracey Book et al. · Journal of Medicinal Chemistry · 1992 · 43 citations

2-Methyl-1,3-dioxaazaspiro[4.5]decanes as novel muscarinic cholinergic agonists

John E. Saunders, Graham A. Showell, Roger J. Snow et al. · Journal of Medicinal Chemistry · 1988 · 24 citations

, , +15

L-687,306: a functionally selective and potent muscarinic M1 receptor agonist

Stephen B. Freedman, Shil Patel, Elizabeth A. Harley et al. · European Journal of Pharmacology · 1992 · 18 citations

, , +9

The potassium channel activator, BRL 34915, antagonises a behavioural response to the muscarinic receptor agonist, pilocarpine

Mark D. Tricklebank, Gail Flockhart, Stephen B. Freedman · European Journal of Pharmacology · 1988 · 12 citations

, , +13

Rows per page

1–5 of 5